deltatrials
Unknown OBSERVATIONAL NCT05534776

Validation of 5-Point Investigator Global Assessments for Pemphigus

Sponsor: Premier Specialists, Australia

Conditions Pemphigus
Updated 5 times since 2022 Last updated: Sep 16, 2022 Started: Sep 21, 2022 Primary completion: Aug 30, 2023 Completion: Aug 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pemphigus, this trial is ongoing. The trial is conducted by Premier Specialists, Australia and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotRecruiting~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown

  2. Oct 2024 — Sep 2025 [monthly]

    Unknown

    Status: RecruitingUnknown

  3. Sep 2024 — Oct 2024 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Sep 2022 — Jul 2024 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Premier Specialists, Australia
Data source: Premier Specialists, Australia

For direct contact, visit the study record on ClinicalTrials.gov .